Dr. Rachel Tate uptoTate
4 years ago
Study out of China, #ABS1892 shows that patient reported outcomes using self assessments are important in AS T2T and decreasing flare rates #ACR20 @RheumNow. https://t.co/ebGtVUg8IV https://t.co/oXvGxQSjtn
Cassandra Calabrese CCalabreseDO
4 years ago
What are you doing at 12pm today on this #ACR20 Monday? I will be listening to @LCalabreseDO discuss the importance of #empathy in rheumatology @HealioRheum @RheumNow https://t.co/E1cH39z64p
Dr. Rachel Tate uptoTate
4 years ago
#ABS0597 All PR-COIN centers found telemed visits met provider needs & 18/19 centers believed telemed visits met pedi-rheum pt needs. Reasons for in-person visit included presence of active dz, worsening condition, & parent request/desire. #ACR20 @RheumNow https://t.co/yun6QCv4fX https://t.co/l9BrVMdJEa
Dr. John Cush RheumNow
4 years ago
Abatacept in RA and ILD Patients: Dr Richard Conway (@RichardPAConway) #ACR20
https://t.co/e31VsnXFq5 https://t.co/sCrqLtXFFc
David Liew drdavidliew
4 years ago
The 'triple M' irAEs (myositis/myocarditis/MG): one of the rheumatic irAEs where autoAb are freq pos
Nice systematic review:
any autoAb+ 61% tested
MG+ 59% tested
MSA+ in 27% tested (18/67, 11 had myositis alone)
@NilashaGhosh @lovetolearn27 @got_rheum #ACR20 ABST1574 @RheumNow https://t.co/utSj8yY0fd
k dao KDAO2011
4 years ago
#FDA updates #ACR20 @rheumnow
labeling/warning changes:
belimumab- mortality removed
abatacept - angioedema added
baricitinib -hypersensitivity rxn added
gabapentin & pregabalin - respiratory depression added
sheila RHEUMarampa
4 years ago
Do you routinely request for HLA-B27 in young patients w/ IBP? @RheumNow #ACR20
Hepatitis B, RA and Drug Risk with Drs. Stanley Cohen and Jack Cush
Dr. Cush interviews past ACR president and long-time friend Dr. Stan Cohen on treatment for liver disease in RA patients and new guidelines being released this morning at ACR 2020.
Robert B Chao, MD doctorRBC
4 years ago
Deucravacitinib TYK2i for PsA
Phase2b 16wk, Double-blind, Placebo, RCT
⬆️ACR20/50/70 response vs. PBO
⬆️HAQ-DI response, enthesitis resolution, MDA vs. PBO
*⃣No serious AE
@RheumNow #ACR20 Abs#L03 #ACRbest https://t.co/9Klu2aeEj2
Janet Pope Janetbirdope
4 years ago
When you give IA steroids for knee OA how long do you tell pts it will work for @RheumNow #ACR20 @CRASCRRheum abstr#1650
Mrinalini Dey DrMiniDey
4 years ago
Plenty of great #telemedicine posters in "Measures & Measurement of Healthcare Quality" session! Abs#1584 reports telemedicine improves access to #rheumatology clinics & adherence, eg in those prev without adequate transport provision. #ACR20 @RheumNow
https://t.co/KwVxqcqu7n
Janet Pope Janetbirdope
4 years ago
@uptoTate @RheumNow Agree. MD global is Often SJC taking into consideration activity severity and location of joints. Ex SJC of two ankles or knees is higher MD global than 2 MCPs. All N of SJC are not =. @RheumNow
sheila RHEUMarampa
4 years ago
Using a panel of urinary prtns, data from this study show transferrin, AGP1, ceruloplasmin, MCP1 & sVCAM1 are sig. ⬆in active LN pts.
More studies req'd for confirmation.
Utility in monitoring renal response to tx?
@RheumNow #ACR20 abs1796 https://t.co/3Zicpz3uDd
Janet Pope Janetbirdope
4 years ago
IA steroids for knee OA did NOT ^ X-ray progression to TKR vs IA Hyaluronic acid! Data from 2 cohorts, n=792 knees. Similar X-rays for single & multiple injections of either Rx. Not Randomized but helpful! Abstr#1652 @RheumNow #ACR20 @CRASCRRheum https://t.co/1yzr5QkIzV
Dr. Rachel Tate uptoTate
4 years ago
New PT-CDAI showed agreement w/ MD(DO)-CDAI at id-ing active vs. controlled RA. Results suggest that PT-based swollen joints were more c/w physician assessments than PT tender joint counts. Useful for telemed! #ACR20 @RheumNow @Janetbirdope #ABS0483 https://t.co/tozp9qBRXT